Surgalign Spine Technologies, Inc. et al. v. LifeNet Health
Docket No. 2021-1117-18, -1236 (IPR2019-00569, -00570) (https://cafc.uscourts.gov/opinions-orders/21-1117.OPINION.4-11-2022_1934157.pdf) (Non-Precedential)
NEWMAN (D), SCHALL, PROST
April 11, 2022
Brief Summary: IPR obviousness decision reversed, claim construction affirmed, other no obviousness decision affirmed.
Summary: Surgalign appealed USPTO (“Board”) IPR decision finding it failed to prove the invalidity of certain of LifeNet’s claims, and LifeNet cross-appealed the determination that others were proven unpatentable. The patents at issue are US 8,182,532 and US 6,458,158 have “substantially identical specifications” and relating to composite bone grafts for use in spinal fusion. “Pertinent to Surgalign’s appeal, independent claim
Continue Reading IPR obviousness decision reversed, another affirmed along with claim construction decisions